Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Cachexia, Anamorelin Ghrelin Agonist

Jose Garcia

MD, PhD

🏢University of Washington School of Medicine🌐USA

Professor and Chief, Endocrinology

44
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jose Garcia has been the principal investigator on the ROMANA trials establishing anamorelin (a ghrelin receptor agonist) as an approved treatment for cancer anorexia-cachexia in Japan and Asia. His research has characterized ghrelin receptor signaling as a therapeutic target in cancer cachexia and explored hormonal and endocrine approaches to muscle preservation. He has contributed to developing consensus criteria for cachexia clinical trial endpoints.

Share:

🧪Research Fields 研究领域

anamorelin ghrelin agonist cachexia
ROMANA trial anamorelin NSCLC
ghrelin signaling appetite cachexia
testosterone cancer cachexia
NSCLC cancer anorexia-cachexia syndrome

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jose Garcia 的研究动态

Follow Jose Garcia's research updates

留下邮箱,当我们发布与 Jose Garcia(University of Washington School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment